248
Views
61
CrossRef citations to date
0
Altmetric
Research Article

Multiple dimensions of recovery in early psychosis

, , , &
Pages 273-283 | Published online: 11 Jul 2009

  • AMERICAN PSYCHIATRIC ASSOCIATION. (1994). DSMIV: Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington, DC: American Psychiatric Association.
  • AMERICAN PSYCHIATRIC ASSOCIATION. (1997). Practice guidelines for the treatment of clients with schizophrenia. American Journal of Psychiatry, 154 (supplement).
  • ANTHONY, W-A. (1993). Recovery from mental illness: the guiding vision of the mental health service system in the 1990s. Psychosocial Rehabilitation Journal, 16, 11-23.
  • BILDER, R.M., GOLDMAN, R.S., ROBINSON, D., REITER, G., BELL, L., BATES, J.A., PAPPANDOPULOS, E., WILLSON, D.F., ALVIR, J.M., WOERNER, M.G., GEISLER, S., KANE, J.M. & LIEBERMAN, J.A. (2000). Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. American Journal of Psychiatry, 157, 549-559.
  • BIRCHWOOD, M., FOWLER, D. & JACKSON, C. (2001). Early interventton in psychosis: a guide to concepts, evidence and interventions. New York: Wiley & Sons.
  • BLACK, K., PETERS, L., RUI, Q., MILLIKEN, H., WHITEHORN, D. & KOPALA, L.C. (2001). Duration of untreated psychosis predicts treatment outcome in an early psychosis program. Schizophrenia Research, 47, 215-222.
  • BROWN, J.A., WHITEHORN, D, RICHARD, J., RUI, Q. & KOPALA, L.C. (2001). Association of premorbid adjustment at age twelve mat global functional outcome at two-year follow-up: initial results from the Nova Scotia Early Psychosis Program. Poster presented at the International Congress on Schizophrenia Research.
  • CANADIAN ASSOCIATION OF OCCUPATIONAL THERAPISTS. (1997). Enabling occupation: an occupational therapy perspective. Ottawa: CAOT Publications.
  • CANADIAN PSYCHIATRIC ASSOCIATION. (1998). Canadian clinical practice guidelines for the treatment of schizophrenia. The Canadian Journal of Psychiatry, 43 (Suppl), 25s-40s.
  • COLLABORATIVE WORKING GROUP ON CLINICAL TRIAL EVALUATIONS. (1998). Assessing the effects of atypical antipsychotics on negative symptoms. Journal of Clinical Psychiatry, 59 (Suppl 12), 28-34.
  • CRAIG, J., BROMET, E.J., PENNING, S., TANENBERGKARANT, M., LAVELLE, J. & GALAMBOS, N. (2000). Is there an association between duration of untreated psychosis and 24-month clinical outcome in a firstadmission series? American Journal of Psychiatry, 157, 60-66.
  • CROWN, M., WHITEHORN, L., MILLIKEN, H., DAVIDSON, C., WHITEHORN, D. & KOPALA, L.L (2001). Evaluating family psycho-education in early psychosis: the Nova Scotia Early Psychosis Program (NSEPP) experience. Presentation at International Congress on Schizophrenia Research.
  • DEEGAN, P. (1988). Recovery: the lived experience of rehabilitation. Psychosocial Rehabilitation Journal, 11, 11-19.
  • DICKERSON, F.B. (1997). Assessing clinical outcomes: the community functioning of persons with serious mental illness. Psychiatric Services, 48, 897-902.
  • DECON, L., POSTRADO, L., DELAHANTY, J., FISCHER, P., LEHMAN, A. (1999). The association of medical comorbidity in schizophrenia with poor physical and mental health. Journal of Nervous & Mental Disease, 187, 496-502.
  • DRAKE, R.J., HALEY, C.J., AKHTAR, S. & LEWIS, S.W. (2000). Causes and consequences of duration of untreated psychosis in schizophrenia. British Journal of Psychiatry, 177, 511-515.
  • FISHER, A.G. (1999). Assessment of motor and process skills (3rd Edition). Colorado:Three Star Press.
  • GOLDMAN, H.H., SKODOL, A.E. & LAVE, TR. (1992). Revising Axis V for DSM-IV: a review of measures of social functioning. American Journal of Psychiatry, 149, 1148-1156.
  • GREEN, M.F. (1996). What are the functional consequences of neurocognitive deficits in schizophrenia? American Journal of Psychiatry, 153,321-330.
  • HAFNER, H., LOFFLER, W, MAURER, K., HAMBRECHT, M. & HEIDEN, W. (1999). Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatrica Scandinavica, 100,105-118.
  • JONES, S.H., THORNICROFT, G., COFFEY, M. & DUNN, G. (1995). A brief mental health outcome scale: reliability and validity of the Global Assessment of Functioning (GAF). British Journal of Psychiatry, 166, 654-659.
  • KANE, J., HONIGFELD, G., SINGER, J. & MELTZER, H. (1988). Clozapine for the treatment-resistant schizophrenic: a double blind comparison with chlorpromazine. Archives of General Psychiatry, 45, 789-796.
  • KAY, S.R., FISZBEIN, A. & OPLER, L.A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261-267.
  • KOPALA, L. C., FREDRIKSON, D, GOOD, K.P. & HORNER, WG. (1996). Symptoms in neuroleptic-naive, firstepisode schizophrenia: response to risperidone. Biological Psychiatry, 39,296-298.
  • KOPELOWICZ, A., ZARATE, R., TRIPODIS, K., GONZALEZ,V.,MINTZ, J. (2000). Differential efficacy of olanzapine for deficit and nondeficit negative symptoms in schizophrenia. American Journal of Psychiatry, 157, 987-993.
  • LARSEN, T.K., JOHANNESSEN, J.O., GULDBERG, C., OPJORDSMOEN, S., VAGLUM, P., MCGLASHAN, TH. (1999). Early intervention programs in first-episode psychosis and reduction of duration of untreated psychosis (DUP). Schizophrenia Research, 36,344.
  • LARSEN5TK., McGLASHAN5TH. & MOB, L.C. (1996).First-episode schizophrenia: I. Early course parameters. Schizophrenia Bulletin, 22,241-256.
  • LARSEN, TK., MOE, L.C., VIBE-HANSEN, L. & JOHANNESSEN, J.O. (2000). Premorbid functioning versus duration of untreated psychosis in 1-year outcome in first-episode psychosis. Schizophrenia Research, 45,1-9.
  • LAW, M., BAPTISTE, S., CARSWELL, A., McCOLL, M.A., POLATAJKO, H. & POLLOCK, N. (1998). Canadian Occupational Performance Measure (3rd Edition). Ottawa: CAOT Publications ACE.
  • LBHMAN, A.F., CARPENTER, W.T., GOLDMAN, H.H. & STEINWACHS, D.M. (1995). Treatment outcomes in schizophrenia: implications for practice, policy, and research. Schizophrenia Bulletin, 21, 669-675.
  • LJBERMAN, R.P., KOPELOWICZ, A., VENTURA, J. & GUTKIND, D. (2002). Operational criteria and factors related to recovery from schizophrenia. International Review of Psychiatry, 14, 256-272.
  • LIEBERMAN, J.A. & FENTON,W.S. (2000). Delayed detection of psychosis: causes, consequences and effect on public health. American Journal of Psychiatry, 157, 1727-1730.
  • LIEBERMAN, J., JODY, D., GEISLER, S., ALVIR, J., LOEBEL, A., SZYMANSKI, S., WOERNER, M. & BORENSTEIN, M. (1993). Time course and biological correlates of treatment response in first-episode schizophrenia. Archives of General Psychiatry, 50, 369-376.
  • LINDENMAYER, J.P., GROCHOWSKI, S. & HYMAN, R.B. (1995). Five factor model of schizophrenia: replication across samples. Schizophrenia Research, 14, 229-234.
  • MCGLASHAN, T.H. (1999). Duration of untreated psychosis in first-episode schizophrenia: Marker or determinant of course? Biological Psychiatry, 46, 899-907.
  • MCGORRY, P.D. & JACKSON, H.J. (1999). The recognition and management of early psychosis: a preventative approach. Cambridge: Cambridge Press.
  • MCGORRY, P.D., PHILLIPS, L.J. YUNG, A.R., FRANCEY, S., GERMANO, D, BRAVIN, J., MACDONALD, A., HEARN, N., AMMINGER, P. & O'DWYER, L. (2000). Does early non-pharmacologic intervention alter the course of schizophrenia: a randomized controlled trial of interventions in the pre-psychotic phase of psychotic disorders. Schizophrenia Research, 41, 9.
  • MOLLER, H.J., MULLER, H., BORISON, R.L., SCHOOLER, N.R. & CHOUINARD, G. (1995). A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients. A re-evaluation of the North American risperidone study. European Archives of Psychiatry & Clinical Neuroscience, 245, 45-49.
  • NATIONAL EARLY PSYCHOSIS PROJECT CLINICAL GUIDELINES WORKING PARTY. (1998). Australian clinical guidelines for early psychosis. Melbourne: National Early Psychosis Project, University of Melbourne.
  • RICHARD, J., WHITEHORN, D. & KOPALA, L. (2001). Health outcomes among newly diagnosed clients with schizophrenia and related disorders in the Province of Nova Scotia, Canada. Presentation at the International Congress on Schizophrenia Research.
  • ROY-BYRNE, P., DAGADAKIS, C., UNUTZER, J. & RIES, R. (1996). Evidence for limited validity of the revised Global Assessment of Functioning Scale. Psychiatric Services, 47, 864-866.
  • SINGH, S.P., CROUDACE, T, AMIN, S., KWEICINSKI, R., MEDLEY, L, JONES, P.B. & HARRISON, G. (2000). Three-year outcome of first-episode psychoses in an established community psychiatry service. British Journal of Psychiatry, 176, 210-216.
  • STRAUSS, J.S., HAFEZ, H., LIEVERMAN, P. & HARDING, C.M. (1985). The course of psychiatric disorder III: longitudinal principles. American Journal of Psychiatry, 142,289-296.
  • TOLLEFSON, G.D. & SANGER, TM. (1997). Negative symptoms: a path analytical approach to a doubleblind, placebo and haloperidol controlled clinical trial with olanzapine. American Journal of Psychiatry, 154, 466-474.
  • VON KNORRING, L & LINDSTROM, E. (1998). Principal components and further possibilities with the PANSS. Ada Psychiatrica Scandtnavica, 388 (Suppl), 5-10.
  • WALLACE, C.J., LJBERMAN, R.P., TAUBER, R. & WALLACE, J. (2000). The Independent Living Skills Survey: a comprehensive measure of the community functioning of severely and persistently mentally ill individuals. Schizophrenia Bulletin, 26, 631-658.
  • WHITE, L., HARVEY, P.D., OPLER, L. & LINDENMAYER, J.P. (1997). Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: a multi-site, multi-model evaluation of the factorial structure of the Positive and Negative Syndrome Scale. Psychpathology, 30, 263-274.
  • WHITEHORN, D., LAZIER, L & KOPALA, L (1998).Psychosocial rehabilitation early after the onset ofpsychosis. Psychiatric Services, 49, 1135-1137.
  • YUNG, A.R., PHILLIPS, L.J., MCGORRY, P.D., McFARLANE, C.A., FRANCEY, S., HARRIGAN, S., PATTON, G.G. & JACKSON, H.J. (1998). Prediction of psychosis.British Journal of Psychiatry, 172 (Suppl 33), 14-20.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.